Introduction
Extensive work over the past 10 years has firmly established the insulin signalling pathway as a key regulator of growth (mass increase), S-phase entry, cell size and tissue size in Drosophila and mammals (Leevers and Hafen, 2004) . Many of the Drosophila experiments have been carried out by genetically manipulating the activity of the pathway in developing imaginal discs, and then examining the impact on various growth parameters, either in the imaginal discs themselves or in the adult epithelial tissues that they give rise to (Leevers et al, 1996; Bohni et al, 1999; Goberdhan et al, 1999; Huang et al, 1999; Montagne et al, 1999; Verdu et al, 1999; Weinkove et al, 1999; Gao et al, 2000; Oldham et al, 2000; Zhang et al, 2000; Brogiolo et al, 2001; Ikeya et al, 2002; Radimerski et al, 2002) . These experimental approaches have shown that overexpression of positive components of the insulin signalling pathway increases tissue growth and cell size, sometimes with an accompanying increase in cell number. Conversely, mutation of positive pathway components or overexpression of inhibitors of the pathway reduces tissue growth, cell size and cell number. Thus, imaginal discs have provided an excellent experimental system for establishing the in vivo function of this pathway in a developing epithelial tissue.
Although imaginal discs have been successfully used to analyse changes in cell size, cell-cycle progression and cell number, inherent biological variation makes the fine analysis of more subtle changes in these parameters difficult. Also, the overexpression of dAkt and Dp110 increases tissue and cell size, but does not increase cell number (Verdu et al, 1999; Weinkove et al, 1999) and the reason for this is not known. We have investigated the effect of insulin signalling on cellcycle progression and cell proliferation in a cell culture system where more precise and detailed analyses are possible than in vivo. We used two haemocyte-derived Drosophila cell lines, Kc167 and S2 cells, in which bovine or human insulin can mimic the effects of Drosophila insulin-like peptides (Brogiolo et al, 2001 ) and increase cell size and S-phase entry (Kwon et al, 2002; Bikopoulos et al, 2004; Kim et al, 2004) . We find that although insulin increases progression through the G1/S transition, it can also delay progression from S phase through G2/M, and thereby slow the rate of increase in cell number of these cultured cells. Experiments using dsRNAi and rapamycin show that dTOR/dRaptor signalling is responsible for this effect, and that under certain conditions, inhibiting insulin or dTOR signalling can increase cell number.
Results and discussion

Insulin can slow cell proliferation
We first confirmed the reported effects of insulin on Kc167 and S2 cell signalling and cell size (Kwon et al, 2002; Lizcano et al, 2003; Bikopoulos et al, 2004; Kim et al, 2004; Leevers and Hafen, 2004) . In both cell types, insulin rapidly induces the phosphorylation of dAkt and dS6K on their hydrophobic motifs (S505 and T398, respectively), which is indicative of their activation. Both kinases are phosphorylated within 5 min and remain phosphorylated for at least 96 h (Supplementary Figure S1 ; data not shown; Lizcano et al, 2003; Miron et al, 2003) . Insulin also increases cell size, assessed by forward scatter measurements (obtained by flow cytometry) and cell volume measurements (from a Coulter counter). The size of S2 cells and Kc167 cells increases within a few hours of adding insulin, is reproducibly increased by 15-20% after 48 h and can be observed at all stages of the cell cycle ( Figure 1A and data not shown).
Surprisingly, we found that cultures of S2 and Kc167 cells treated with insulin increase in cell number at consistently slower rates than untreated cultures ( Figure 1B ). This slower increase in cell number is sometimes observed within 24 h, and a 5-15% reduction in cell number is always evident by 48 h. To investigate whether insulin slows the increase in cell number by inducing apoptosis, we examined whether the reduction in cell number could be abrogated by dsRNAimediated depletion of Dronc, an initiator caspase required for S2 cell apoptosis (Igaki et al, 2002; Zimmermann et al, 2002; Kiessling and Green, 2006) . Depletion of Dronc by dsRNAi has no impact on the insulin-induced reduction in cell number although it completely prevents the reduction in cell number induced by dsRNAi of Drosophila inhibitor of apoptosis 1 (DIAP1; Figure 1C ; Muro et al, 2002; Leulier et al, 2006) . Insulin also slows the increase in cell number of S2 cells expressing the baculoviral inhibitor of apoptosis, p35, which blocks the activity of DRICE, the rate-limiting caspase for Drosophila apoptosis (data not shown; Kondo et al, 2006; Muro et al, 2006; Xu et al, 2006) . Furthermore, we were unable to detect an insulin-induced increase in the sub-G1 population of S2 or Kc167 on flow cytometry profiles, which is indicative of cells undergoing apoptosis (data not shown).
Together, these data demonstrate that the slowed increase in cell number of insulin-treated S2 cell cultures arises as a result of slowed cell division rather than increased apoptosis.
Insulin increases the proportion of cells in S phase and G2
To investigate further this unexpected insulin-induced slowing of cell division, we used flow cytometry to examine the cell-cycle profiles of insulin-treated S2 and Kc167 cells. In Drosophila wing imaginal discs, activating the insulin signalling pathway reduces the proportion of cells in G1 and increases the proportion of cells in S and G2 phases (Weinkove et al, 1999; Gao et al, 2000) . This accumulation of cells in S and G2 phases was not accompanied by a significant reduction in cell number and hence was thought to result from insulin signalling accelerating progression from G1 to S phase. We found that treating Kc167 and S2 cells with insulin also reduces the G1 cell population and increases the S-and G2-phase cell population, and that this redistribution of cells takes place over several cell divisions ( Figure 1D ). This effect is less pronounced in Kc167 cells, as, in the absence of insulin, a larger proportion of these cells are in G2/M at any given time ( Figure 1D ). Therefore, all subsequent experiments examining cell-cycle phasing were performed on S2 cells. The reduced proportion of insulin-treated cells in G1 is likely to be due in part to the previously reported accelerated progression from G1 into S phase (Kwon et al, 2002; Bikopoulos et al, 2004; Kim et al, 2004) . However, our observation that insulin reduces the rate of increase in cell number raises the possibility that this change in cell-cycle distribution may also be due to slowed progression from S phase through G2 and M phases. Note that the change in cell-cycle phasing that occurs over 48 h in response to insulin treatment is not the result of cultured cells reaching confluence (Supplementary Figure S2) or a maximal culture density-both control and insulin-treated cells are still increasing in number and size after 48 h ( Figure 1B ).
Insulin delays progression through G2 and M phases
We sought to investigate the effect of insulin on progression from S phase through G2 and M phases in the absence of any experimental artefacts that might be introduced by cell-cycle synchronisation. A pulse of BrdU was used to specifically label the S-phase cells within an asynchronously growing population of S2 cells. These BrdU-positive cells were followed by flow cytometry as they passed from S phase into G2, through mitosis and back into G1 and then S phase (Figure 2A ). Insulin was added to the medium immediately after the pulse-labelling. By 6 h, when a small number of cells have divided and reentered G1, the percentage of BrdUpositive cells in the G1 peak was smaller in insulin-treated cells compared to control cells (13% for insulin-treated cells, 23% for control cells). The ability of insulin to delay progression from S phase through G2, M and into G1 is also evident after 12 h, when 20% of insulin-treated cells are in G1 compared to 36% of control cells. Note that, although the insulin-treated cells move from S phase to G1 more slowly than the control cells, these same cells then progress rapidly through G1 and into S phase. Thus, after 15 h, the proportion of cells in S phase is higher in insulin-treated cells than in control cells ( Figure 2A ). Similar results were obtained with Kc167 cells (data not shown).
A change in the length of one cell-cycle phase is often accompanied by a compensatory adjustment in another phase of the cycle. For example, overexpression of the Drosophila Cdk1 inhibitory kinase, dWee1, in the wing imaginal disc lengthens G2. These cells then compensate to maintain the same cell division time by shortening G1 (Reis and Edgar, 2004) . Thus, the elongation of G2/M observed in insulin-treated S2 cells might conceivably result from a compensation for the insulin-induced shortening of G1. Importantly, this is not the case; insulin was added after the S-phase cells were pulse-labelled with BrdU and so the BrdUpositive cells that were followed through G2 and M phases had gone through a normal G1.
To rule out the possibility that 'insulin shock' is responsible for the effect on progression from G2 through M and into G1, similar experiments were carried out in cells that were grown in insulin for 40 h before labelling with a pulse of BrdU. Under these conditions, insulin treatment results in the same delay in progression from S phase through G2/M ( Figure 2B ). We also examined how quickly insulin is able to delay progression through G2/M, by treating cells with insulin 8 h after the BrdU pulse and analysing their cell-cycle profile 1 h later. Even 1 h of insulin treatment is able to produce a detectable delay in progression from S phase through G2/M ( Figure 2C , 9 h timepoint). Thus, insulin is able to slow the progression of S2 cells from S phase through G2/M within 1 h of its addition and after the cultures have been incubated with insulin for 40 h. Taken together, the data in Figures 1 and 2 lead to the surprising and previously unreported conclusion that insulin can reduce the ability of S2 cells to progress from S phase through G2 and M phases.
Reducing dTOR signalling promotes progression through G2 and M phases
Next, we investigated which molecules on the insulin signalling pathway might mediate the ability of insulin to delay progression from S phase through G2 and M phases. Various 6 cells/ml were pulse-labelled with BrdU for 15 min, grown in the presence or absence of 1 mM insulin and the cell-cycle profiles of BrdU-labelled cells were recorded by flow cytometry. The BrdU-labelled insulin-treated cells pass more slowly from S phase through G2 and M phases (6 and 12 h time points) and more quickly from G1 into S phase (15 h time point). Results shown are representative of four independent experiments. (B) S2 cells seeded at 1 Â10 6 cells/ml were grown in 1 mM insulin for 40 h before labelling with a pulse of BrdU for 15 min. Passage of the BrdU-labelled cells was followed for a further 12 h. The ability of insulin to delay progression through G2/M was apparent after 6, 9 and 12 h. (C) S2 cells seeded at 1 Â10 6 cells/ml were labelled with a pulse of BrdU for 15 min and then 1 mM insulin was added immediately or after 8 h. Passage of the BrdU-labelled cells was followed for 12 h. Even 9 h after BrdU labelling, treatment with insulin for 1 h delayed progression of cells from S phase through G2/M. Results in (B) and (C) are representative of two independent experiments. pathway components were partially depleted using dsRNAi, and a 'mini-screen' was carried out for dsRNAs that can prevent the insulin-induced accumulation of cells in G2 (data not shown). dTOR dsRNAi was most effective and within 48 h significantly reduced the proportion of both control and insulin-treated cells in G2 ( Figure 3B ). Depleting dTOR might reduce the proportion of cells in G2 both by delaying progression through G1/S and by accelerating progression through G2/M. Importantly, and consistent with the latter, over a 48-h period, the partial depletion of dTOR also abrogates the insulin-induced reduction in cell number ( Figure 3A) .
Recent work has shown that TOR functions in two distinct complexes, TORC1 and TORC2, each of which is likely to have several targets (Loewith et al, 2002; Dann and Thomas, 2006) . TORC1contains Raptor and mediates the phosphorylation and activation of S6K (Hara et al, 2002; Kim et al, 2002) , TORC2 contains Rictor and mediates the phosphorylation and activation of Akt (Sarbassov et al, 2005) . Thus, we also examined the effect of dsRNAi depletion of dRaptor, dS6K and dRictor on insulin-stimulated changes in S2 cell-cycle profiles and cell number. To ensure that the predicted proteins were depleted by the dsRNA treatments, cell lysates were analysed by immunoblotting with antibodies against the phosphorylated hydrophobic motifs of dAkt (Ser505) and dS6K (Thr398; Supplementary Figure S3) . Consistent with the ability of TORC1 to activate dS6K, depletion of dTOR and dRaptor reduces phospho-dS6K levels (Lizcano et al, 2003; Leevers and Hafen, 2004; Sarbassov et al, 2005) . Consistent with the ability of TORC2 to phosphorylate dAkt on S505, depletion of dTOR and dRictor reduces phospho-dAkt levels (Supplementary Figure S3 ; Sarbassov et al, 2005) . Finally, consistent with the negative feedback of S6K on molecules higher up the insulin signalling pathway, depletion of dS6K slightly increased dAkt phosphorylation (Harrington et al, 2005) . Depletion of dRaptor and, to a lesser extent, dS6K mimics the effect of dTOR depletion and reduces the insulinstimulated accumulation of cells in G2 and reduction in cell number. In contrast, depletion of dRictor has little effect ( Figure 3A and B). Together, these data imply that dTORC1, possibly via its activation of dS6K, can delay progression from S phase through G2/M, whereas dTORC2 cannot.
To investigate further the influence of dTOR on progression through G2/M, we treated cells with rapamycin, which inhibits the activity of TORC1 (Dann and Thomas, 2006) and thus abolishes dS6K phosphorylation in S2 cells (data not shown; Lizcano et al, 2003) . Cells were treated with rapamycin for 1 h, then insulin was added for 48 h and cellcycle profiles and cell number were assessed. In contrast to what happens when dTOR signalling is partially inhibited by dTOR dsRNAi, cells treated with 100 nM rapamycin go through an initial round of cell division, nearly doubling their cell number at 24 h ( Figure 3C) , and then by 48 h most of these cells accumulate in G1 and cell number does not increase further ( Figure 3C and D) . Non-rapamycintreated cells, with and without insulin, continue to increase in cell number and do not accumulate in G1 (Figure 3C and D).
We examined whether lower doses of rapamycin (1 nM) would inhibit dTOR more weakly and increase cell number at 48 h, thereby mimicking the effect of dTOR dsRNAi. Whereas the ability of 1 nM rapamycin to arrest cells in G1 and inhibit proliferation was reduced at both 24 and 48 h compared to 100 nM rapamycin, 1 nM rapamycin did not increase cell number relative to the control as was observed with dTOR dsRNAi (Figure 3C and D) . Treatment with even lower doses of rapamycin was ineffective and had no effect on signalling or proliferation (data not shown). Our inability to observe the same changes in cell number and cell-cycle distribution in cells treated with dTOR dsRNA and rapamycin may be due to the molecular, temporal and kinetic complexities of the TORC1 and TORC2 signalling complexes and their sensitivity to rapamycin (for example, see Harrington et al, 2005; Sarbassov et al, 2006) .
Nevertheless, we sought to examine whether rapamycinmediated inhibition of dTOR impairs the ability of insulin to delay progression from S phase through G2 and M phases during the initial cell cycle that occurs immediately before cells treated with 100 nM rapamycin accumulate in G1. Changes in the cell-cycle profiles of BrdU pulse-labelled cells treated with or without 100 nM rapamycin and insulin were followed over 15 h. Importantly, we found that the BrdU-labelled cells pass more quickly from S phase through G2/M when treated with rapamycin, in the presence or absence of insulin ( Figure 4A , compare G1 population in DMSO-and rapamycin-treated cells at 9 and 15 h).
Histone H3 is phosphorylated at its amino terminus late in G2 and is required for chromosome condensation during mitosis (Hendzel et al, 1997) . Because histone H3 becomes completely dephosphorylated by telophase, its phosphorylation state is a strong and precise marker for mitosis and can be used to determine a mitotic index (the percentage of cells in a population in mitosis at any one time; Tapia et al, 2006) . To confirm that insulin treatment inhibits and rapamycin treatment accelerates the progression of cells from S phase into G2/M, S2 cells were treated as described above, then fixed and stained with anti-phosphohistone H3 after 9 h (when the changes in cell-cycle progression first become obvious in the BrdU pulse-chase experiment). After 9 h, the percentage of S2 cells in mitosis decreases from approximately 8.0% in control cells to approximately 4.6% in insulin-treated cells. Furthermore, rapamycin increased the percentage of cells in mitosis to approximately 12.9 and 11.5% in control and insulin-treated cells, respectively (Figures 4B). Together, our data demonstrate that insulin and TOR signalling have two distinct effects on cell-cycle progression, and independently accelerate progression from G1 to S phase and slow progression from S phase through G2 and M phases.
Insulin is less able to delay progression through G2 and M phases when nutrients are low
The molecular connections on the insulin and TOR signalling pathways are complex, involving positive and negative feedback loops, and the activity of TOR is influenced by both insulin and amino-acid levels (Leevers and Hafen, 2004; Dann and Thomas, 2006) . Thus, we hypothesise that the TOR-mediated delay in progression from S phase through G2 and M phases may only have a detectable impact on cell number under certain experimental conditions. For example, the partial depletion of dTOR, and presumably dTORC1 and dTORC2, by dsRNAi for 48 h increases cell number presumably because it accelerates progression through G2/M more than it delays progression through G1/S ( Figure 3A and B) . In contrast, more complete inhibition of dTORC1 signalling with rapamycin reduces cell number, presumably because although progression through G2/M is accelerated, the delayed progression through G1/S is more pronounced (Figure 3C and D) .
To investigate further whether different experimental manipulations of dTOR signalling can have different outcomes for cell number, we examined whether the ability of insulin to slow the increase in S2 cell number can be altered by different nutrient conditions. The S2 cell culture medium was serially diluted with PBS to deplete it of amino acids and other nutrients, thereby reducing dTOR signalling. The cells were allowed to adapt to the new medium for 24 h, then insulin was added for a further 48 h. As expected, diluting the growth medium reduces basal and insulin-stimulated dS6K phosphorylation ( Figure 5A ; Radimerski et al, 2002) . Importantly, under these conditions of reduced nutrients and dTOR signalling, the ability of insulin to slow the increase in cell number of S2 cell cultures was reduced ( Figure 5B , compare control versus insulin cell number in Figure 4 Inhibiting the dTOR/dRaptor complex with rapamycin promotes progression from S phase through G2/M phase. (A) S2 cells seeded at 1 Â10 6 cells/ml were pulse-labelled with BrdU for 15 min and then grown in the presence or absence of 100 nM rapamycin and 1 mM insulin. The cell-cycle profiles of the BrdUlabelled cells fixed at the time points shown were recorded by flow cytometry. The ability of rapamycin to accelerate progression from S phase through G2 and M phases and into G1 is evident after 9 h and more marked by 12 h. Data are indicative of three independent experiments. (B) Cells were seeded at 1 Â10 6 cells/ml, then grown in the presence or absence of 100 nM rapamycin and 1 mM insulin for 9 h and immunostained with anti-phospho-H3. 25 or 100% Schneider's medium). Thus, the ability of dTOR to delay progression through G2/M and thereby reduce cell number in S2 cells is detectable only when high nutrient levels synergise with insulin to maximally activate dTOR signalling.
Inhibiting dTOR signalling can increase cell number in the Drosophila wing
Our data demonstrate that under certain conditions in S2 cells, insulin signalling can delay progression through G2/M and reduce cell number. Moreover, partially reducing dTOR signalling by dsRNAi can accelerate progression through G2/M and increase cell number. Such effects have not been reported in other experimental systems, perhaps because sufficiently sensitive analyses have not been performed or because effects on G2/M were masked by coincident effects on G1/S.
We investigated whether inhibiting dTOR signalling in another experimental system, the Drosophila wing, can also promote progression through G2 and M phases, thereby increasing cell number. At the end of larval development, the proliferation of cells in the wing imaginal disc slows and they accumulate in G2 (Neufeld et al, 1998) . Two additional mitoses occur during early pupal development, then cells arrest and differentiate into the adult wing. We fed larvae 5 and 10 mM rapamycin, to weakly inhibit dTOR signalling during the last 24 h of larval development and then examined adult wings to see whether extra cell divisions, resulting in increased wing cell number, had occurred. Each wing blade cell possesses a single wing hair; so for each wing, the number of cells within a fixed area was counted and the entire wing area was measured and then the hypothetical number of cells per wing was calculated.
As expected, feeding larvae 10 mM rapamycin to inhibit dTOR signalling reduced wing size (by 13%, Po0.001) wing cell number (by 6%, Po0.001); and wing cell size (by 10%, Po0.001, Figure 6 ). Importantly, although feeding larvae 5 mM rapamycin slightly reduced wing size (by 4%, P ¼ 0.06), these wings contain 6% more cells than control wings (Po0.001) and were composed of cells that were 8% smaller (Po0.001). Thus, very slight reductions in dTOR Figure 5 Insulin is less able to delay progression through G2 and M phases when nutrients are low. S2 cells seeded at 1 Â10 6 cells/ml were grown in Schneider's medium that was serially diluted with PBS (before adding 10% FBS) for 24 h. (A) Insulin was added for 15 min and then cell lysates were prepared and analysed by immunoblotting to demonstrate that nutrient depletion reduces basal and insulin-stimulated dS6K phosphorylation. (B) The cells were grown for a further 48 h in 1 mM insulin and then Coulter counter cell count data were recorded. Data shown represent mean data7s.d. from three replicates (*Po0.01) and are representative of three independent experiments. Figure 6 Weak inhibition of dTOR signalling increases Drosophila wing cell number. Drosophila larvae were transferred to food containing 10 or 5 mM rapamycin or ethanol (control) 96 h after egg laying and then the wings of emerging adult males were analysed. (A) Rapamycin at 10 mM (green) reduces wing size and increases wing cell density, whereas 5 mM rapamycin (blue) has less effect on wing size but still increases wing cell density. The hypothetical number of cells per wing was calculated and plotted against wing size (B) or used to calculate the mean wing cell number (C). Data are shown as mean percentage changes7s.d., n ¼ at least 20. Rapamycin at 5 mM increases total wing cell number, indicating that inhibiting dTOR signalling can increase the total number of cell divisions that occur during wing development. Data shown are representative of three independent experiments. signalling during wing development, can significantly increase cell number ( Figure 6B ), supporting the idea that dTOR signalling can also inhibit progression through G2/M in vivo in developing wing imaginal discs.
To summarise, by doing short time-scale BrdU pulse-chase experiments on large cell populations, we show that insulin can slow the progression of cultured Drosophila cells from S phase through G2 and M (Figure 2A) , and that mild inhibition of dTOR-dRaptor can actually accelerate cell division (Figure 3 ). Although it is not possible to carry out these types of experiments in vivo, our rapamycin feeding experiments show that, in principle, lowering dTOR signalling can have the same effect during wing development (Figure 6 ). Thus, our data uncover a new connection between TOR signalling and the cell cycle, and demonstrate that TOR can have dual and opposing effects on cell-cycle progression.
Why should the same signalling pathway both accelerate progression through G1/S and delay progression from S phase through G2/M? It is already known that various cells can maintain their cell-cycle time and accommodate alterations in the rates of progression through one cell-cycle transition (for example, G1/S) by inducing a compensatory change in the rate of progression through another cell-cycle transition (for example G2/M: Reis and Edgar, 2004) . Feedback mechanisms involving components of the cellcycle machinery are responsible for at least some of this 'cell-cycle compensation'. Our data show that cells that have been through a normal G1/S-phase transition, then are labelled in S phase with BrdU and treated with insulin still go from S phase through G2/M more slowly. Thus, the ability of insulin to slow progression through G2/M is independent of its ability to accelerate progression through G1/S, and so is not solely due to a feedback mechanism involving the cellcycle machinery.
Perhaps the dual and opposing effects of this signalling pathway on cell-cycle progression have evolved as a mechanism to prevent 'runaway cell division' under high nutrient conditions. This response may also have evolved to allow starving cells to pass rapidly through mitosis, an energy consuming process, before their full response to starvation can begin. Interestingly, when Schizosaccharomyces pombe are starved, they increase their cell division rate within 1 h and divide at a smaller size Nurse, 1977, 1978) . Although this observation has been taken to support the existence of a G2/M cell size checkpoint that is under nutrient control, it might also indicate that it is beneficial for cells to divide as rapidly as possible once they are starved. Indeed, the induction of autophagy, a cellular response to nutrient deprivation that provides a source of amino acids to allow cell survival, is inhibited in mitotic cells until they have exited telophase (Eskelinen et al, 2002) . If autophagy cannot be induced until cells have reentered the G1 phase of the cell cycle, the rapid passage of starved cells through G2/M would ensure that minimal time, energy and resources are wasted, and that autophagy can begin more quickly. Intriguingly, inhibiting TOR can also induce autophagy (Noda and Ohsumi, 1998; Cutler et al, 1999; Abeliovich et al, 2000; Kamada et al, 2000; Gutierrez et al, 2004; Ravikumar et al, 2004; Guertin and Sabatini, 2005) ; so lowered TOR signalling may have dual roles that aid cell survival during starvation. The inhibition of TOR signalling may both promote the rapid progression of cells in S phase, through G2/M and into G1, and, once the cells are in G1, induce autophagy to provide an alternative supply of nutrients.
Further experiments are required to characterise the molecular connections responsible for the ability of reduced levels of nutrients and TOR signalling to induce cell division. Intriguingly, in Xenopus eggs, rapamycin treatment rapidly increases the translation of the CDK phosphatase, Cdc25A, which promotes cell division (Schwab et al, 1999) . Indeed, Thomas speculated that inhibiting TOR signalling might reduce cell size by inducing cell division at a smaller than normal size, because of this increased translation of Cdc25A (Thomas, 2000) . Such a molecular mechanism should also result in accelerated cell division, and thus allow cells to begin autophagy more rapidly upon starvation.
Materials and methods
Cell culture
Kc167 and S2 cells were cultured at 231C in Schneider's medium (Gibco) supplemented with 10% foetal bovine serum (FBS), 50 U/ml penicillin and 50 mg/ml streptomycin (Invitrogen, complete medium). For experiments, cells were seeded at a concentration of 1 Â10
6 cells/ml in 75 cm 2 flasks (30 ml per flask) or in six-well plates at 3 ml per well). Bovine insulin (Sigma-Aldrich) was used at a concentration of 1 mM. For rapamycin treatment, 1 or 100 nM rapamycin (Sigma-Aldrich) was added to the culture medium 1 h before insulin stimulation. For experiments with diluted Schneider's medium, cells were seeded in PBSA-diluted Schneider's medium supplemented with 10% FBS for 24 h before insulin treatment.
Cell volume, cell count and cell-cycle analysis
Kc167 and S2 cells were cultured as described above in six-well plates and triplicate wells were used for each time point. A total of 300 ml from each well was diluted in 15 ml of Isoton (BeckmanCoulter) and analysed for cell volume and cell count using a Z2 Coulter Counter (Multisizer II, Beckman-Coulter). The remaining cells were collected by centrifugation, fixed by vortexing and incubating in cold 70% ethanol at 41C for at least 30 min, then washed twice in PBSA and resuspended in 500 ml of 20mg/ml RNaseA (Sigma-Aldrich) and 40 mg/ml propidium iodide in PBSA (Sigma-Aldrich). Propidium iodide-stained cells were analysed on a FACScalibur flow cytometer using CellQuest (Becton Dickinson).
BrdU pulse-chase experiments S2 cells were cultured as described above in six-well plates for 12 h, 15 mM BrdU (Sigma-Aldrich) was added for 15 min and then the cells were washed with PBSA. After three washes, BrdU-free medium plus or minus 1 mM insulin was added to wells. In experiments where rapamycin was used, medium plus or minus 100 nM rapamycin was added to cells after the PBSA washes. At 1 h after rapamycin incubation, 1 mM insulin was added to medium.
Cells were harvested at the time points specified by pipetting, collected by centrifugation, fixed in cold 70% ethanol and stored at 41C. Subsequent steps were performed at room temperature. Fixed cells were washed twice in PBSA, permeabilised by incubating in 2 M HCl for 30 min and then washed twice in PBSA and once in PBS-BT (PBSA þ 0.1% BSA þ 0.2% Tween 20). A 2 ml portion of monoclonal mouse anti-BrdU (Becton Dickinson) was added directly to the cell pellet. This was incubated for 20 min in the dark and then cells were washed twice in PBS-BT and incubated in 50 ml of FITC-conjugated rabbit anti-mouse F(ab 0 )2 fragments (DAKO) diluted 1:10 in PBS-BT for 20 min. Cells were washed in PBSA, treated with 50 ml 100mg/ml RNaseA (Sigma-Aldrich) for 15 min and 250 ml 40 mg/ml propidium iodide for a further 30 min and then analysed by flow cytometry. dsRNAi DNA templates for dsRNA synthesis were PCR amplified from fly genomic DNA using primers that contained 5 0 T7 RNA polymerasebinding sites preceded by a GAA overhang and followed by sense or antisense sequences. The following primers were used: dTOR: sense primer 5 0 -CGAACCTTATGCTGGATCGT-3 0 , antisense primer 6 cells were seeded in 1 ml of complete medium per well of a six-well plate, 25 mg of dsRNA was added, cells were incubated for 1 h and then a further 2 ml complete medium was added.
Immunofluorescence S2 cells were seeded at 1 Â10 6 cells/ml on glass coverslips coated with polylysine. The cells were allowed to adhere for 30 min, then 100 nM rapamycin or DMSO (control) was added to the medium for 1 h, followed by 1 mM insulin and the plates were incubated at 231C for a further 9 h. Cells were fixed in PLP (periodate lysine paraformaldehyde ¼ 0.2 M lysine buffer adjusted to pH 7.4 with 0.2 M NaH 2 PO 4 and 0.2 M Na 2 HPO 4 with 2% final paraformaldehyde concentration added just before fixation) at room temperature for 20 min. Coverslips were washed three times in PBS þ 0.3% Tween 20, incubated for 1 h in blocking buffer (PBS þ 1% Tween 20 þ10% goat serum) and then incubated overnight in blocking buffer containing polyclonal anti-phospho-histone H3 (Ser10) diluted 1/500 (Upstate). Coverslips were washed four times in blocking buffer and incubated for 1 h in Alexa Fluor 488 donkey anti-rabbit IgG (Molecular Probes) diluted 1/1000 in blocking buffer. Coverslips were washed three times in PBS þ 0.3% Tween 20 and once in PBS and then mounted on slides and to visualised on a Nikon Eclipse1000 Fluorescence microscope using a Nikon Plan Apo Â 100 objective. Images were acquired and processed using Openlab 4.0.4.
Western blotting
Cells were lysed in 50 mM Tris-HCl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 1% (v/v) Triton X-100, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 0.27 M sucrose, 0.1% (v/v) 2-mercaptoethanol and Complete TM Protease Inhibitor mixture (Roche). Then the extracts were cleared of nuclei and debris by centrifugation for 10 min at 13 000 r.p.m. A 75 mg portion of protein per lane was resolved on NuPage TM 4-12% gradient SDS-PAGE gels (Invitrogen), transferred onto Immobilon-P membranes (Millipore) and analysed by immunoblotting as described (Lizcano et al, 2003) . Primary antibodies used include affinity-purified polyclonal rabbit anti-CTdAKT (Lizcano et al, 2003) and anti-phospho-dAKT (Ser505) (Lizcano et al, 2003) sheep anti-dS6K (Lizcano et al, 2003) , and the polyclonal rabbit anti-phospho Drosophila p70 S6K (Thr389, Cell Signalling Technology). Secondary antibodies were conjugated to Alexa Fluor 680 (Molecular Probes) or IRDye TM 800 (Rockland Immunochemicals), and signals were detected using the linear Odyssey Infrared Imaging System (LI-COR Biosciences).
Feeding larvae rapamycin
First instar yw larvae were picked from 1 h egg lays, seeded at a density of 70 larvae per vial and maintained at 251C. At 96 h after egg laying, larvae were transferred to vials containing food plus 5 mM rapamycin, 10 mM rapamycin or ethanol (control). Male wings were mounted and analysed as described (Marygold et al, 2005) .
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